Jonathan D. Root - 26 May 2022 Form 4 Insider Report for Inari Medical, Inc.

Role: Director
Signature: /s/ Angela Ahmad, attorney-in-fact for Jonathan Root, M.D.
Issuer symbol: N/A
Transactions as of: 26 May 2022
Net transaction value: $0
Form type: 4
Filing time: 27 May 2022, 16:26:57 UTC
Previous filing: 28 Feb 2022
Next filing: 13 Jun 2022
SEC filing: View on sec.gov

Key filing fact

Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 27 May 2022.

Key facts

This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
3 reported transactions and 1 derivative row are listed below.
Filing timestamp: 27 May 2022, 16:26.

Change

Previous filing in this sequence was filed on 28 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

NARI transaction

Common Stock

Award

Transaction value: $0
Shares: +2,420
Change %: +0.46%
Price: $0.000000
Shares after: 528,646
Date: 26 May 2022
Ownership: Direct
Footnotes: F1

NARI transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,983
Change %: +0.56%
Price: $0.000000
Shares after: 531,629
Date: 27 May 2022
Ownership: Direct

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 335
Date: 26 May 2022
Ownership: Directly Owned by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

NARI transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -2,983
Change %: -50%
Price: $0.000000
Shares after: 2,982
Date: 27 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,983
Exercise price: $0.000000
Footnotes: F2

^* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id	Content
F1	Represents RSUs granted on May 26, 2022, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2023 annual meeting.
F2	The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of common stock for each RSU. 1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .